Feedback / Questions
EVO756 - Evommune, Maruho
https://www.prnewswire.com/news-releases/evommune-presents-full-phase-2-data-for-oral-mrgprx2-inhibitor-evo756-in-chronic-inducible-urticaria-during-late-breaker-at-eadv-2025-congress-302560722.html
Sep 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next